semaglutide vs t Zepbound Wegovy: A Comprehensive Guide to New Weight Loss Medications Not all GLP-1s are the

BPC-157 500mcg Rapid Pro by Infiniwell (formerly Tailor Made Health & DNA Health)

Matthew Johnson, PhD, a senior researcher for the Center of Excellence for Psilocybin Research and Treatment at Sheppard Pratts Institute for Advanced Diagnostics and Therapeutics

Contains the same active ingredient (tirzepatide) as branded weight loss medications

GLP-1 Agonists Market to Reach USD 170.75 Billion by 2033 GLP-1 Analogues Market to Worth USD 170.75 billion in 2033 Download PDF Brochure: The global GLP-1 agonists market is expected to reach USD 170.75 billion in 2033 from USD 64.42 billion in 2025 at a CAGR of 13.0% during the forecast period

Thats because the active ingredient, semaglutide, will no longer be binding to the GLP-1 receptors in your body to control your appetite